Berikutnya

Putar otomatis

Clinical Trial for Advanced Bile Duct Cancer

0 Tampilan • 07/01/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis